Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject
Status:
Completed
Trial end date:
2020-04-28
Target enrollment:
Participant gender:
Summary
The objective of this present study was to asses the pharmacokinetic properties of acyclovir
tablet from new product formulation (PT. Kimia Farma (Persero) Tbk) to its innovator product,
Zovirax® tablet (Glaxo Wellcome S.A., Aranda, Spain)